NCT00098384View on ClinicalTrials.gov

Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea

PHASE2CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

September 30, 2003

Conditions
Diarrhea
Interventions
DRUG

rifaximin

Trial Locations (1)

Unknown

Universidad Autonoma de Guadalajara, Guadalajara

All Listed Sponsors
collaborator

Bausch Health Americas, Inc.

INDUSTRY

collaborator

The University of Texas Health Science Center, Houston

OTHER

lead

DuPont, Hurbert L., MD

INDIV

NCT00098384 - Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea | Biotech Hunter | Biotech Hunter